[ALNY] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
05-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -50.52%
YoY- -47.33%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 8,687 18,642 8,495 16,759 20,884 20,587 20,455 -43.52%
PBT -21,053 -9,575 -72,760 -19,502 -12,956 -11,368 -14,303 29.42%
Tax -2,884 -562 -10,572 -2,543 -2,855 -414 -237 429.85%
NP -18,169 -9,013 -62,188 -19,502 -12,956 -11,368 -14,303 17.30%
Tax Rate - - - - - - - -
Total Cost 26,856 27,655 70,683 36,261 33,840 31,955 34,758 -15.81%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -209.15 -48.35 -732.05 -116.37 -62.04 -55.22 -69.92 107.74%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.29 -0.15 -1.20 -0.38 -0.25 -0.25 -0.31 -4.35%
EPS Diluted -0.29 -0.15 -1.20 -0.38 -0.25 -0.25 -0.31 -4.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.